2005, Number 73
<< Back Next >>
Rev Enfer Infec Pediatr 2005; 18.19 (73)
Risk of early neonatal infection in newborns of pregnant women colonized with Streptococcus agalactie serotype III
Reyna-Figueroa J, Ortiz-Ibarra FJ, Beltrán-Zúñiga M, Villeda-Gabriel G, Limón-Rojas AE
Language: Spanish
References: 14
Page: 13-17
PDF size: 44.41 Kb.
ABSTRACT
Objective: To establish the index of association between the genital colonization with Group B Strep (GBS) serotype III from pregnancy women and early neonatal sepsis.
Material and methods: We studied, stocks of GBS corresponding to pregnant women. Later the clinical files of mothers’ products were reviewed. We defined 2 groups: Exposed, new born from mothers with GBS serotype III infection documented, in cervical or urinary culture, and not exposed: newborns from mothers with serotypes Ia, Ib, II, IV, V or VI infection documented.
The sample size was obtained calculating difference of proportions, with a relation from 1 to 2. The statistical analysis was made by means of measures of central tendency and dispersion. The comparison between groups was made through Students T and Chi square or exact Fisher tests, depending on the variables and the expected values in the 2 tables of 2 x 2. The association force was considered.
Results: We serotype a total of 134 stocks of SGB. In the exposed group we included 42 NB of pregnant women colonized with SGB serotype III, whereas in not exposed group 92 products of pregnant women colonized with serotypes different from III.
By means of the bivaried analysis was that the SGB presence serotype III, has a RR of 5,5 (2,0 - 14, IC 95%) p ‹0.05
REFERENCES
Baker CJ, and Edwards MS. 1995. Group B streptococcal infections, p. 980-1054. In J S Remington and J O Klein (ed.), Infectious diseases of the fetus and newborn infant, 4th ed. W.B. Saunders, Philadelphia, Pa.
Baker C. Infecciones por Estreptococo del grupo B. Clin Perinatol, 1997; 1: 59-71
Moller M, Thomsen AC, Borch K, Dinesen K, Zdravkovic M. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 1984 14; 2: 69-70
Helmig R, Uldbjerg, Borins J, Kilian M. Clonal analysis of Streptococcus agalactiae Isolated from Infants with Neonatal Sepsis or Meningitis and their Mothers and from Healthy Pregnant Women. JID 1993; 168: 904-909
Solórzano SF, Echaniz AG, Conde GC, Calderón JE, Arredondo GJ, Beltrán ZM. Cervicovaginal infection with Group B Streptococci among Pregnant Mexican women. J infect Dis 1989; 159: 1003-4
Solórzano SF, Diaz RR, Arredondo G J. Diseases caused by group B Streptococcus in México. Ped Infect Dis J 1990; 9: 66
Palacios CG, Eskew KE, Solórzano SF, Mattingly JS. Decreased Capacity for Type -Specific-Antigen Synthesis Accounts for High Prevalence of Nontypeable Strains of Group B Streptococci in Mexico. J Clin Microbiol. 1997: 35; 2923-2926
Narcio RM, Solórzano SF, Arredondo GJ, Calderón JE, Beltrán ZM. Etiología de la Infección cervicovaginal en pacientes embarazadas y no embarazadas. Ginec Obst Mex 1989; 57: 41-46.
Walsh AJ, Hutchins S. Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines. Pediatr Infect Dis J. 1989; 8: 271-276.
Feng YC, Clemens DJ, Azimi HP, Regan JA. Capsular polysaccharide Types of Group B Streptococcal Isolates from neonates with Early-Onset Systemic infection. JID 1998; 177: 790-2
Reyna FJ 2004 Infección por Streptococcus agalactiae, p. 233-245. En Casanova R G, Ortiz IFJ, Reyna FJ (ed.), Infecciones de Transmisión Sexual, 1ra ed. Alfil, México DF.
Carrasco MI, Reyna FJ, Beltrán ZM, Segura CE, Ortiz IFJ, Figueroa DR. Perfil clínico y demográfico de pacientes Gineco-obstétricas colonizadas por Streptococcus agalactiae. Ginec Obstet Mex 2002; 70: 521-526.
Ortiz IFJ, Reyna FJ, Casanova RG, Villegas MMI. Streptococcus agalactiae importancia de la quimioprofilaxis en la prevención de la infección perinatal. Enf Infec y Micro 2004: 24 (4): 120-124.
Morbility and Mortality Weekly Report. Prevention of Perinatal Group B Streptococcal Disease, Revised Guidelines from CDC. 2002; 51: RR11.